Here are three notes:
1. The $49.25 per share offer from TPG Capital is a 17.3 percent increase to its $42 per share offer in October.
2. Exatech’s board agreed to the amended terms and expects to close the all-cash deal during the first quarter of 2018.
3. When the deal was announced Oct. 23, Exatech’s stock has hovered at $42. However, on Monday, Dec. 4, the company’s stock was trading at $49.25.
More articles on devices and implants:
Global spinal fusion devices market to reach nearly $11B by 2025: 6 observations
Mazor Robotics CEO under investigation for insider trading: 3 things to know
Precision Medical opens 3rd Indiana location — 6 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
